revenue outlook larg unchang spend littl achiev
key focu item today result outlook see higher
oper spend along non-recur item achiev
top-lin growth alreadi bake consensu margin
pressur larg tie legal expens corpor restructur china mfg
larger sale forc legal restructur expens expect neg
impact ebit margin one-tim natur context
achiev oper margin within long-term rang sinc
follow acceler invest describ management expect
oper margin improv within long-term guidanc
help drive top-lin growth middl rang algn long-
term guidanc incorpor declin y/i basi
project organ revenue growth line street view
investor psycholog high growth view investor histor
will accept annual oper spend volatil med tech compani
long visibl translat continu organ revenu hyper-growth
believ fit criteria invisalign franchis still penetr
ww orthodont case start track continu organ sale
compound-annual-growth-rate investor look past today ep reduct vs prior
street view make sens oper play offens clear
align land grab tradit metal brace still share
practition enter align ecosystem scanner case management softwar invisalign
clear align translat long-term annuiti stream trim
ep estim factor invest higher
tax consist coverag shift valuat basi
new pt base price-to-earnings ep
importantli sale estim rel unchang
quarterli annual ep usd
lower usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
overweight compani market leader
clear align still earli stage
adopt clear align north american
market expect drive
upsid case see greater adopt clear
align better asp current project
believ would warrant multipl expans
given strong leverag greater ep growth
downsid case see continu asp declin
multipl compress growth compani fall
favor continu invest spend mute ep
growth would lead lower multipl
project
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
margin
two key topic discuss compani call asp trajectori
compani margin guidanc
first compani expect full year flat asp
suggest world-wide y/i asp declin gener in-lin
consensu model perhap slightli better fear sharp declin
compani guidanc factor compani variou discount program
expect similar program occur manag larg
point continu mix-shift fx declin posit
compani comprehens non-comprehens product line see asp
improv suggest mix shift fx primari
culprit asp declin quarter
margin compani make variou one-tim invest restructur
alongsid increas sale forc legal expens put pressur oper
margin restructur legal expens expect neg
impact oper margin margin point
beyond sg item compani gross margin expect pressur
year freight cost seemingli increas compani also
transit align fabric china outsid juarez mexico
facil due shift fabric compani chines facil underutil
transit period
host factor inform compani guidanc outlook
summar figur gener compani top-lin guidanc metric mirror
compani long term outlook howev compani margin profil seemingli take
hit due part higher legal expens hire sale rep shift
manufacturing/fabr one facil anoth higher freight cost plan
corpor structur reorgan increas legal fee plan corpor
structur reorgan drag oper margin import note
restructur one-tim item wont repeat
post revenu mln well compani guidanc mln
street expect mln revenu compris case volum
high end guidanc ww
scanner revenu higher expect mln guidanc flat
scanner revenu ep guidanc rang
shipmentsmiddl mlninvisalign revenuesmiddl rangescannersmiddl rangegross marginsimprov cours lt sg mlnop marginimprov cours op margin rangefi rangeincl lega feestax incl mln excess tax miladjust milequ loss mil/qtrnoteshir gp rep americas/em expens org ep stronger op profit rang barclay align technolog
align year guidanc tablerevenu growthprovid analyst daygross analyst dayoper expens revsprovid analyst dayoper analyst revsprovid analyst daybuyback milprovid analyst day barclay align technolog
 annual revenu model align modelactualactualactualactualprojectedprojectedprojectedprojectedcas ship geographi american american gp america case changenorth american american gp america case mixnorth american american gp america case case patient world-wide world-wide util case per north american american gp american util util case per north american american gp american util changenorth american american gp american util sell price asp north american asp provid asp barclay changenorth american asp provid asp barclay align sale mil north changenorth barclay
 annual incom statement addback check expens rate interest check ep fulli dilut share growth expens barclay
 annual revenu model align modelactualactualactualactualprojectedprojectedprojectedcas ship geographi american american gp america case changenorth american american gp america case mixnorth american american gp america case case patient world-wide world-wide util case per north american american gp american util doc case period formula north american american gp american util changenorth american american gp american util sell price asp north american asp provid asp barclay changenorth american asp provid asp barclay align sale mil north changenorth barclay
 annual incom statement addback check expens rate interest check ep fulli dilut share growth expens barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
